Michael Gelband’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$359K Buy
39,228
+27,137
+224% +$299K ﹤0.01% 1322
2026
Q1
$139K Buy
+12,091
New +$160K ﹤0.01% 1417
2025
Q1
Sell
-28,635
Closed -$500K 1843
2024
Q4
$500K Sell
28,635
-18,081
-39% -$314K ﹤0.01% 1154
2024
Q3
$730K Buy
+46,716
New +$748K ﹤0.01% 1070
2024
Q1
Sell
-270,506
Closed -$3.65M 1834
2023
Q4
$3.65M Sell
270,506
-116,887
-30% -$1.37M 0.02% 416
2023
Q3
$4.98M Sell
387,393
-60,275
-13% -$1.08M 0.05% 375
2023
Q2
$8.09M Buy
447,668
+317,079
+243% +$5.92M 0.07% 297
2023
Q1
$2.19M Buy
130,589
+97,137
+290% +$1.9M 0.02% 840
2022
Q4
$687K Buy
33,452
+4,269
+15% +$75.3K 0.01% 1076
2022
Q3
$558K Sell
29,183
-9,499
-25% -$214K 0.01% 1332
2022
Q2
$911K Buy
38,682
+20,325
+111% +$582K 0.01% 1126
2022
Q1
$600K Buy
18,357
+8,165
+80% +$262K 0.01% 1428
2021
Q4
$317K Buy
10,192
+4,177
+69% +$140K ﹤0.01% 1639
2021
Q3
$229K Buy
6,015
+128
+2% +$5.1K ﹤0.01% 1731
2021
Q2
$236K Sell
5,887
-2,521
-30% -$107K ﹤0.01% 1891
2021
Q1
$364K Buy
+8,408
New +$371K 0.01% 1543

Other funds holding OFIX

Michael Gelband's OFIX Position: Q2 2026 in Review

Michael Gelband increased its Orthofix Medical (OFIX) stake by 224% in Q2 2026, buying an estimated $299K and bringing the position to 39,228 shares worth $359K. The position accounts for ﹤0.01% of the portfolio, ranked #1322.

Michael Gelband first reported a position in OFIX in Q1 2021 and has held it in 16 quarters since. The position peaked at $8.09M in Q2 2023. 142 funds tracked by Wall St. Rank hold OFIX as of Q2 2026.

  • Michael Gelband held 39,228 shares of Orthofix Medical worth $359K as of Q2 2026.
  • Michael Gelband bought 27,137 Orthofix Medical shares in Q2 2026, an estimated $299K.
  • Orthofix Medical made up ﹤0.01% of Michael Gelband's portfolio in Q2 2026, its #1322 holding.
  • Michael Gelband first reported a position in Orthofix Medical in Q1 2021 and has held it in 16 quarters since.
  • Michael Gelband's Orthofix Medical position peaked at $8.09M in Q2 2023.
  • 142 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.